Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This proposal aims to develop essential technologies for rapid and accurate SARS-CoV-2 antibody test in serum and droplet blood using microflow cytometry immunoassay (MCIA) for on-site testing. The test will assess levels of immunoglobin G (IgG) and immunoglobin M (IgM) antibodies produced in response to SARS-CoV-2 exposure. Unfortunately, none of the antibody testing tools currently available are suited for rapid and accurate on-site testing. The proposed MICA antibody test would serve as a much-needed on-site test method of infection and immunity screening. The developed antibody testing can change the game in the fight against COVID-19. The proposed MCIA antibody test is a revolutionary new tool that offers faster and more accurate SARS-CoV-2 infection and immunity testing compared to existing methods, providing on-site test results within mere minutes, completely altering the trajectory of the COVID-19 pandemic.
Chang-Qing Xu
Jianxi Qu;Yushan Zhang;Tyler Kashak
Forsee Instruments
Engineering
Manufacturing
McMaster University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.